Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | FNTA | P49354 | 2/20 | 0.37 |
| ▸ | FNTB | P49356 | 2/20 | 0.37 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.35 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.35 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.35 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL11238030 | 0.91 | FNTA (0.36) | TDP1ALDH1A1FFAR3THRBFNTA | |
| SCHEMBL42603 | 0.85 | FFAR3 (0.53) | TDP1ALDH1A1FFAR3THRBFNTA | |
| SCHEMBL42601 | 0.85 | FFAR3 (0.53) | TDP1ALDH1A1FFAR3THRBFNTA | |
| SCHEMBL101165 | 0.85 | FFAR3 (0.53) | TDP1ALDH1A1FFAR3THRBFNTA | |
| Methacrylic Acid SCHEMBL20335186 | 0.82 | TDP1 (0.44) | TDP1ALDH1A1FFAR3THRBHSD17B10 | |
| Methacrylic Acid SCHEMBL5866439 | 0.82 | FFAR3 (0.62) | TDP1ALDH1A1FFAR3THRBHSD17B10 | |
| Methacrylic Acid SCHEMBL270686 | 0.82 | TDP1 (0.62) | TDP1ALDH1A1FFAR3THRBHSD17B10 | |
| Methacrylic Acid SCHEMBL1628181 | 0.82 | FFAR3 (0.62) | TDP1ALDH1A1FFAR3THRBHSD17B10 | |
| SCHEMBL11335133 | 0.82 | ALDH1A1 (0.48) | TDP1ALDH1A1FFAR3THRBFNTA | |
| SCHEMBL11335137 | 0.82 | ALDH1A1 (0.48) | TDP1ALDH1A1FFAR3THRBFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120164210-A1 | PHOTODYNAMIC THERAPEUTIC AGENT HAVING CELL-SPECIFIC ACTIVE ACCUMULATION PROPERTIES | THE UNIVERSITY OF TOKYO | 2012-06-28 | — | — | US | disclosed |
| EP-2374825-A1 | PHOTODYNAMIC THERAPEUTIC AGENT SHOWING ACCUMULATION OF CELL-SPECIFIC FUNCTIONS | Keio University (JP) | 2011-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164210-A1 | PHOTODYNAMIC THERAPEUTIC AGENT HAVING CELL-SPECIFIC ACTIVE ACCUMULATION PROPERTIES | CD47, CD44, EPCAM | TDP1 2688/4885ALDH1A1 329/4885FFAR3 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.